Form 497VPU HANCOCK JOHN VARIABLE

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

SEPARATE ACCOUNTS A, N, S, U, UV, AND V

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

SEPARATE ACCOUNT B

Supplement dated May 28, 2025 to the Statutory Prospectuses,

Updating Summary Prospectuses, and Initial Summary Prospectuses,

dated April 28, 2025

Changes to Variable Investment Options

This Supplement is intended for distribution with the Statutory Prospectuses, Updating Summary Prospectuses, and Initial Summary Prospectuses, as applicable, (each a “prospectus”) dated April 28, 2025 for variable life insurance contracts issued by John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York, as applicable. The affected prospectuses belong to the following policies:

Portfolio Name Change and Subadvisor Change

Effective on or about May 28, 2025 (the “Effective Date”), the Capital Appreciation Trust will be renamed as listed below:

On or about the Effective Date, the renamed portfolio’s subadvisor will be replaced as indicated below:

As a result, after the Effective Date, all references in the prospectuses to the Former Name and Former Subadvisor are changed to the New Name and New Subadvisor, respectively.

Changes to Current Expenses

On or about the Effective Date, there is a reduction in “Current Expenses” for the JHVIT U.S. Growth Trust in the “Appendix: Portfolios Available Under the Contract” section of the prospectus.

Accordingly, the name, subadvisor, and “Current Expenses” of the JHVIT Capital Appreciation Trust Series NAV portfolio are deleted in the “Appendix: Portfolios Available Under the Contract” section of each prospectus and replaced with the following:

* This portfolio’s annual expenses reflect temporary fee or expense waivers or reimbursements.

You should read this supplement together with the prospectus for the contract you purchased and retain both documents for future reference.

Prior to making any investment decisions, you should carefully review your product prospectus and all applicable supplements. In addition, you should review the prospectuses and applicable supplements for the underlying portfolios that we make available as investment options under the policies. The prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the portfolios. In the case of any of the portfolios that are operated as feeder funds, you should also review the prospectus for the corresponding master fund. If you need to obtain additional copies of any of these documents, please contact your representative or contact our Service Office at the address or telephone number on the back page of your product prospectus.